Mangoceuticals MGRX
NASDAQ MGRX
$0.30 +0.02 (+7.10%)
At close: Oct 20, 2026 · 4:00 PM EDT

Mangoceuticals (MGRX) Current Debt (2024 - 2025)

Updated

Mangoceuticals (MGRX) reported Current Debt of $75,000 for Q4 2025, compared with -$37,500 a year earlier.

Analysis

Mangoceuticals (MGRX) Current Debt (2024 - 2025) Analysis & Trends

For FY2025, Mangoceuticals posted Current Debt of $175,000, up 16.7% from FY2024.

  • By year, Current Debt came in at $150,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 HCA Healthcare 102.50 Bn 98.51 Bn - 1.24 Bn
2 Natera 58.05 Bn 53.74 Bn 485.19 Mn -
3 Labcorp Holdings 26.39 Bn 24.13 Bn 1.11 Bn -150.00 Mn
4 Quest Diagnostics 26.28 Bn 24.41 Bn 1.03 Bn -
5 Tenet Healthcare 22.71 Bn 11.72 Bn - -
6 Guardant Health 21.59 Bn 17.65 Bn 219.03 Mn -
7 BrightSpring Health Services 12.87 Bn 11.21 Bn 492.75 Mn -
8 Fresenius Medical Care AG 12.49 Bn 4.44 Bn 1.52 Bn 398.20 Mn
9 Encompass Health 12.04 Bn 11.70 Bn - -
10 Mangoceuticals 5.14 Mn 2.77 Mn 44,215.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 75,000.00
Dec 31, 2024 -37,500.00
API Access

Mangoceuticals Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=MGRX&period=max&api_key=YOUR_API_KEY